Tesamorelins FDA approval in 2010 was specifically for HIV-associated lipodystrophy, following pivotal trials published in The Lancet that demonstrated an approximately 15% reduction in visceral adipose tissue over 26 weeks
And even the ones that are approved are typically indicated for very specific conditions
Supplement Facts: Serving Size: 12.5 ml Servings Per Container: 40 Amount Per Serving: L-Carnitine: 1500 mg Protein: 0 g Carbohydrate: 0 g of which sugars: 0 g Fat: 0 g of which saturates: 0 g Fibre: 0 g Salt: 0 g *RI - Reference Intake Ingredients: Water, citric acid, flavourings, preservative potassium sorbate, thickening agent cellulose gum, carrot and blackcurrant concentrate for color, coloring for apricot flavor beta-carotene, sodium benzoate
That was quite a number of years ago
Nasal Drug Delivery Devices: Characteristics and Performance in a Clinical PerspectiveA Review
The protective effect of ursodeoxycholic acid in an in vitro model of the human fetal heart occurs via targeting cardiac fibroblasts